Log In
BCIQ
Print this Print this
 

BF-1

  Manage Alerts
Collapse Summary General Information
Company Biofrontera AG
DescriptionSerotonin (5-HT2B) receptor antagonist
Molecular Target Serotonin (5-HT2B) receptor
Mechanism of ActionSerotonin (5-HT2B) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationMigraine
Indication DetailsPrevent migraine
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today